跳至主要内容
临床试验/NCT04420078
NCT04420078已完成不适用

Brugada Ablation of VF Substrate Ongoing MultiCenter Registry

Pacific Rim Electrophysiology Research Institute1 个研究点 分布在 1 个国家目标入组 159 人开始时间: 2017年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
159
试验地点
1
主要终点
Death

研究概览

简要总结

Current treatment of high-risk Brugada Syndrome (BrS) patients (pts) with recurrent VF is limited. Catheter ablation (CA) has been performed for BrS but a large study with long-term outcomes of CA in BrS ablation are lacking.

详细描述

Brugada syndrome (BrS) patients who undergo BRS substrate ablations from tertiary centers for catheter ablations of complex arrhythmias from three continents - Asia, Europe and North America - are registered in a common database. The investigators exclude patients who were lost to follow up in the outpatient clinic.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Symptomatic Brugada Syndrome patients who had undergone catheter ablation of the arrhythmogenic substrates.

排除标准

  • Patients who will not commit to regular follow up.

结局指标

主要结局

Death

时间窗: 3 years

Expiration, unrelated to procedure

ICD Therapy for VT/VF

时间窗: 3 years

Electrical therapy delivered through device for termination of VF episodes

次要结局

  • Inappropriate ICD Therapy(3 years)
  • Normalization of Brugada ECG pattern(3 years)

研究者

发起方
Pacific Rim Electrophysiology Research Institute
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验